abstract |
The present invention relates to novel substituted imidazol [1,2-b] pyridazine compounds of formula I, pharmaceutical compositions thereof, and the use of such compounds as antagonists of the factor 1 receptor that releases corticotropin (CRF1) in the Treatment of psychiatric disorders or neurological diseases. |